Chimerix, Inc.
Chimerix, Inc. (CMRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CMRX · as of Jun 9, 2026
Key Statistics
Explore Chimerix, Inc. Data
cmrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 56.0%
The CMRX analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month price target is $8.55, representing +0.12% upside from the current price of $8.54.
Competitors & Peers
cmrx competitorsCMRX
ALBO
ASLN
CDMO
GRCL
HARPStock Performance
Full HistoryAbout Chimerix, Inc.
Chimerix, Inc. operates as a biopharmaceutical company, committed to advancing therapeutic solutions that improve the lives of individuals grappling with severe medical conditions. Its sole approved m…
what is chimerix, inc. · cmrx stock overview · chimerix, inc. company profile · who is chimerix, inc. ceo · cmrx NASDAQ · chimerix, inc. headquarters · chimerix, inc. business segments
About Stock Overview & Key Data
Chimerix, Inc. (CMRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 11, 2013. As of the latest trading session, CMRX stock price is $8.54, with a market capitalization of $801.1M. The stock has returned +775.90% over the past 12 months and +151.92% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Chimerix, Inc. stock is Buy, with an average 12-month price target of $8.55. In fiscal year 2024, Chimerix, Inc. reported revenue of $212000.00 and net income of -$88.4M. For detailed data — including Chimerix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Chimerix, Inc. (CMRX) stock price is $8.54. The stock is traded on NASDAQ under the ticker symbol CMRX. The 52-week range is $0.75 – $8.55.